[Form 4] La Rosa Holding Corp. Insider Trading Activity

Rhea-AI Filing Summary

Michael A. La Rosa, a director of La Rosa Holdings Corp. (LRHC), reported an insider acquisition. On 08/11/2025 he was granted 600 shares of restricted common stock that vest on the grant date and were recorded as acquired at a $0 price. Following the transaction he beneficially owns 600 shares, held in a direct capacity. The Form 4 was signed by Mr. La Rosa on 08/18/2025 and filed to disclose the change in beneficial ownership.

Insights

Corporate Governance Expert

TL;DR: Director received a small grant of 600 restricted shares that vested immediately; disclosure complies with Section 16 reporting.

The Form 4 shows a routine insider grant to a director under the company's equity incentive plan. The shares are restricted but vesting on grant means immediate beneficial ownership is established and properly disclosed. The filing includes the reporting person's name, relationship (director), transaction date (08/11/2025), number of shares (600), and signature date (08/18/2025), aligning with Section 16 requirements.

Securities Analyst

TL;DR: The transaction is minor in scale (600 shares) and is disclosed promptly; it is unlikely to be material to investors on its own.

The report documents acquisition of 600 shares at a $0 price described as restricted common stock granted under the 2022 Equity Incentive Plan, vesting on the grant date. The disclosure is concise and includes the necessary identifiers (issuer LRHC, reporting person, dates). No derivative instruments, dispositions, or additional terms were reported.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LA ROSA MICHAEL A

(Last) (First) (Middle)

1420 CELEBRATION BLVD.,

2ND FLOOR

(Street)

CELEBRATION FL 34747

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
La Rosa Holdings Corp. [ LRHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	08/11/2025		A		600	A	$0	600	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of restricted common stock, vesting on the date of the grant, granted pursuant to the Second Amended and Restated La Rosa Holdings Corp. 2022 Equity Incentive Plan.

	/s/ Michael A La Rosa	08/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Michael A. La Rosa report on Form 4 for LRHC?

He reported an acquisition of 600 shares of restricted common stock on 08/11/2025, vesting on the grant date.

What is Michael A. La Rosa's relationship to La Rosa Holdings Corp. (LRHC)?

The Form 4 lists him as a Director of La Rosa Holdings Corp.

What price was reported for the acquired shares in the Form 4?

The shares were reported with a price of $0, consistent with a grant of restricted stock.

How many shares does Michael A. La Rosa beneficially own following the reported transaction?

He beneficially owns 600 shares following the reported transaction.

When was the Form 4 signed and filed?

The Form 4 was signed by Michael A. La Rosa on 08/18/2025; the transaction date reported is 08/11/2025.